129 related articles for article (PubMed ID: 36973112)
21. An Individualised Strategy and Long-Term Outcomes of Endovascular Treatment of Budd-Chiari Syndrome Complicated by Inferior Vena Cava Thrombosis.
Ding PX; He X; Han XW; Zhang Y; Wu Y; Liang XX; Liu C
Eur J Vasc Endovasc Surg; 2018 Apr; 55(4):545-553. PubMed ID: 29478911
[TBL] [Abstract][Full Text] [Related]
22. Computational fluid dynamics simulation of time-resolved blood flow in Budd-Chiari syndrome with inferior vena cava stenosis and its implication for postoperative efficacy assessment.
Zhao Y; Ping J; Yu X; Cui Y; Yin J; Sun C; Hua G; Wang C; Li X; Tang L
Clin Biomech (Bristol, Avon); 2021 Feb; 82():105256. PubMed ID: 33508562
[TBL] [Abstract][Full Text] [Related]
23. Inferior Vena Cava Rupture Caused by Balloon Angioplasty During the Treatment of Budd-Chiari Syndrome.
Ding PX; Han XW; Liu C; Ding JY; Lee EW
Cardiovasc Intervent Radiol; 2019 Oct; 42(10):1398-1404. PubMed ID: 31342098
[TBL] [Abstract][Full Text] [Related]
24. Endovascular Management of Budd-Chiari Syndrome with Inferior Vena Cava Thrombosis: A 14-Year Single-Center Retrospective Report of 55 Patients.
Meng X; Lv Y; Zhang B; He C; Guo W; Luo B; Yin Z; Fan D; Han G
J Vasc Interv Radiol; 2016 Oct; 27(10):1592-603. PubMed ID: 27397618
[TBL] [Abstract][Full Text] [Related]
25. Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases.
Takayasu K; Muramatsu Y; Moriyama N; Wakao F; Makuuchi M; Takayama T; Kosuge T; Okazaki N; Yamada R
Am J Gastroenterol; 1994 Feb; 89(2):249-53. PubMed ID: 8304312
[TBL] [Abstract][Full Text] [Related]
26. Accuracy of computed tomographic angiography in the diagnosis of patients with inferior vena cava partial obstruction in Budd-Chiari syndrome.
Liu SY; Xiao P; Cao HC; Jiang HS; Li TX
J Gastroenterol Hepatol; 2016 Dec; 31(12):1933-1939. PubMed ID: 27118067
[TBL] [Abstract][Full Text] [Related]
27. Prognostic model for identifying candidates for hepatectomy among patients with hepatocellular carcinoma and hepatic vein invasion.
Zhang XP; Wang K; Gao YZ; Wei XB; Lu CD; Chai ZT; Zhen ZJ; Li J; Yang DH; Zhou D; Fan RF; Yan ML; Xia YJ; Liu B; Huang YQ; Zhang F; Hu YR; Zhong CQ; Lin JH; Fang KP; Cheng ZH; Wu MC; Lau WY; Cheng SQ;
Br J Surg; 2020 Jun; 107(7):865-877. PubMed ID: 32246475
[TBL] [Abstract][Full Text] [Related]
28. Recurrence of hepatocellular carcinoma 102 months after successful eradication and removal of membranous obstruction of the inferior vena cava.
Takamura M; Ichida T; Yokoyama J; Matsuda Y; Nomoto M; Aoyagi Y
J Gastroenterol; 2004 Jul; 39(7):681-4. PubMed ID: 15293140
[TBL] [Abstract][Full Text] [Related]
29. Multiple hyperplastic nodular lesions of the liver in the Budd-Chari syndrome: a case report and review of published reports.
Wang Y; Xue H; Jiang Q; Li K; Tian Y
Ann Saudi Med; 2015; 35(1):72-5. PubMed ID: 26142943
[TBL] [Abstract][Full Text] [Related]
30. Acute Budd-Chiari syndrome associated with non-viral cryptogenic hepatocellular carcinoma: revisiting the 'chicken or the egg' theory.
Søreide K
Hepatogastroenterology; 2014; 61(130):388-90. PubMed ID: 24901147
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of individualized interventional treatment for primary Budd-Chiari syndrome complicated by inferior vena cava thrombosis.
Sun X; Zhang J; Duan F; Wang M
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e642-e649. PubMed ID: 34034280
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma in Budd-Chiari syndrome: characteristics and risk factors.
Moucari R; Rautou PE; Cazals-Hatem D; Geara A; Bureau C; Consigny Y; Francoz C; Denninger MH; Vilgrain V; Belghiti J; Durand F; Valla D; Plessier A
Gut; 2008 Jun; 57(6):828-35. PubMed ID: 18218675
[TBL] [Abstract][Full Text] [Related]
33. Survival and prognostic indicators of Budd-Chiari syndrome: a systematic review of 79 studies.
Qi X; Ren W; Wang Y; Guo X; Fan D
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):865-75. PubMed ID: 25754880
[TBL] [Abstract][Full Text] [Related]
34. Surgical outcomes of hepatocellular carcinoma invading hepatocaval confluence.
Li W; Wu H; Han J
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):593-601. PubMed ID: 27919848
[TBL] [Abstract][Full Text] [Related]
35. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
36. Transatrial stent placement for treatment of inferior vena cava obstruction secondary to extension of intracardiac tumor thrombus from hepatocellular carcinoma.
Wallace MJ
J Vasc Interv Radiol; 2003 Oct; 14(10):1339-43. PubMed ID: 14551283
[TBL] [Abstract][Full Text] [Related]
37. Preoperative predictors of short-term survival after hepatectomy for multinodular hepatocellular carcinoma.
Zhao WC; Zhang HB; Yang N; Fu Y; Qian W; Chen BD; Fan LF; Yang GS
World J Gastroenterol; 2012 Jul; 18(25):3272-81. PubMed ID: 22783052
[TBL] [Abstract][Full Text] [Related]
38. Budd-Chiari syndrome/hepatic venous outflow tract obstruction.
Valla DC
Hepatol Int; 2018 Feb; 12(Suppl 1):168-180. PubMed ID: 28685257
[TBL] [Abstract][Full Text] [Related]
39. Proposal of selection criteria for operative resection of hepatocellular carcinoma with inferior vena cava tumor thrombus incorporating hepatic arterial infusion chemotherapy.
Kasai Y; Hatano E; Seo S; Taura K; Yasuchika K; Okajima H; Kaido T; Uemoto S
Surgery; 2017 Oct; 162(4):742-751. PubMed ID: 28705491
[TBL] [Abstract][Full Text] [Related]
40. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
